首页> 外国专利> Diaromatic compounds derived from a salicylic unit and their use in human and veterinary medicine and in cosmetics

Diaromatic compounds derived from a salicylic unit and their use in human and veterinary medicine and in cosmetics

机译:水杨酸单元衍生的芳族化合物及其在人兽药和化妆品中的用途

摘要

Diaromatic compounds, characterised in that they correspond to the following general formula: ##STR1## in which: R.sub.1 is --CH.sub.3, - -CH. sub.2 OH, --COR.sub.8 or --CH.sub.2 OCOR.sub.9, R.sub.8 is H, OH, -- OR. sub.10, --N(rr') or alkyl, R.sub.10 is alkyl, alkenyl, aryl or aralkyl, r and r' being H, alkyl, aryl, aralkyl, etc., r and r' together form a heterocycle, R.sub.9 is alkyl, alkenyl or a sugar residue, R.sub.2 and R. sub.3 are --OR.sub.11 or --OCOR.sub.11, R.sub.11 is H, alkyl, fluoroalkyl, aryl or aralkyl, R.sub.3 in addition being H, R.sub.4 is H, OH, alkyl, alkoxy, F, Cl or --CF.sub.3, R.sub.5 and R.sub.7 are H, OH, alkoxy, . alpha.-substituted alkyl or ,'-disubstituted alkyl, etc., R. sub.6 is H, OH, alkyl, alkoxy, cycloalkyl, etc., R.sub.5 and R. sub.7 cannot simultaneously be OH or alkoxy and R.sub.4, R.sub.5, R.sub.6 and R. sub.7 cannot simultaneously be H, R.sub.5 and R.sub.6 or R.sub.6 and R. sub.7 can form, with the aromatic ring, a ring with 5 or 6 members, X is chosen from amongst:PP(i) --C(R.sub.13 R.sub.14)-- C(R.sub. 16 R.sub.18)--W--, (ii) --C(R.sub.14)--W--R.sub.16 C(R.sub.18 R. sub.19)--, (iii) --C(R.sub.13 R.sub.14)--C(R.sub.15 R.sub.16)--C(R.sub.18 R.sub.20)- -, (iv) --CR.sub.17 CR.sub.21 --C(R.sub.13 R.sub.14)-- P Pin which:PPW is O, --NR.sub.12 or S(O). sub.n, n=0, 1 or 2, R.sub.13, R.sub.15 and R.sub.20 are H, --OR.sub.11, -- OCOR.sub.11 etc., R.sub.14, R.sub.16, R.sub.18 and R.sub.19 are H, aralkyl, alkyl, etc., when X is (i) R.sub.13 and R.sub.14 can form N--OR.sub.11 or . dbd.N--OCOR.sub.11, when X is (iii) or (iv), R.sub.14, R.sub.16 and R.sub. 18 are also --OR.sub.11 or --OCOR.sub.11, or R.sub.13, R.sub.14 or R.sub. 15, R.sub.16 taken together can form NOR.sub.11 or N--OCOR.sub. 11, R.sub.12 is H, alkyl, aralkyl, alkenyl, alkynyl or fluoroalkyl, R.sub. 17 is H, hydroxyl, alkyl or alkoxy, R.sub.21 is H or alkyl, and the salts of the compounds of formula (I).
机译:对话化合物,其特征在于它们对应于以下通式:其中R 1是-CH 3,-CH是。 sub.2 OH,-COR.sub.8或-CH.sub.2 OCOR.sub.9,R.sub.8是H,OH,-OR。 sub.10,-N(rr')或烷基,R.sub.10是烷基,烯基,芳基或芳烷基,r和r'是H,烷基,芳基,芳烷基等,r和r'共同形成杂环,R.sub.9是烷基,烯基或糖残基,R.sub.2和R.sub.3是-OR.sub.11或-OCOR.sub.11,R.sub.11是H,烷基,氟代烷基,芳基或芳烷基,R.sub.3另外是H,R.sub.4是H,OH,烷基,烷氧基,F,Cl或-CF.3,R.sub .5和R.7是H,OH,烷氧基,...。 R.sub.6是H,OH,烷基,烷氧基,环烷基等,R.sub.5和R.sub.7不能同时是OH或烷氧基和R.sub.4,R.sub.5,R.sub.6和R.sub.7不能同时为H,R.sub.5和R.sub.6或R.sub.6和R. sub.7可以与芳环形成具有5个或6个成员的环,X选自:[P]

(i)--C(R.sub.13 R.sub.14)- -C(R.sub。16 R.sub.18)-W--,(ii)--C(R.sub.14)-W--R.sub.16 C(R.sub.18 R.sub.19)-,(iii)--C(R.sub.13 R.sub.14)-C(R.sub.15 R.sub.16)-C(R.sub。 18 R.sub.20)--(iv)--CR.sub.17 CR.sub.21 --C(R.sub.13 R.sub.14)-

其中:

W是O,-NR.sub.12或S(O)。 sub.n,n = 0、1或2,R.sub.13,R.sub.15和R.sub.20是H,-OR.sub.11,-OCOR.sub.11等,当X为(i)R 13和R 14时,R 14,R 16,R 18和R 19为H,芳烷基,烷基等。可以形成N--OR.sub.11或。 dbd.N–OCOR.sub.11,当X为(iii)或(iv)时,R.sub.14,R.sub.16和R.sub。 18也是--OR.sub.11或--OCOR.sub.11,或R.sub.13,R.sub.14或R.sub。如图15所示,R.sub.16可以一起构成NOR.sub.11或N--OCOR.sub。在图11中,R 12是H,烷基,芳烷基,烯基,炔基或氟代烷基。 17是H,羟基,烷基或烷氧基,R 21是H或烷基,以及式(I)化合物的盐。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号